Alnylam Pharmaceuticals
ALNY
#642
Rank
HK$245.15 B
Marketcap
HK$1,894
Share price
-1.30%
Change (1 day)
61.23%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company